Daily Equity Report 24 Sep 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 24THSEPTEMBER 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK The benchmark indices continued their upward momentum on the second day on September 23 post corporate tax cut by the Finance Minister on September 20. At close, the Sensex was up 1,075.41 points CLOSE PREVIOUS at 39090.03, while Nifty was up 329.20 points at 11,603.40. NIKKEI About 1604 shares have advanced, 971 shares declined, and 182 shares are unchanged. BPCL, Bajaj Finance, Eicher Motors, IOC and L&T were among major gainers on the Nifty, 2091.52 while losers were Zee Entertainment, Infosys, Tata Motors, SECTORIAL INDICES Power Grid and Dr Reddy’s Labs. GLOBAL FACE CLOSE CHANGE (%) 11749.0 2.78 ! 9487.55 2.78 Asian Market - Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.16%, while the 4575.10 2.74 Shanghai Composite led the Hang Seng lower. They fell 0.98% and 0.81% respectively. 6004.30 2.75 30548.45 5.41 ! U.S. Market - North and South American markets finished mixed as of the most recent closing prices. The IPC gained CLOSE CHANGE (%) 1.26% and the Bovespa rose 0.46%. The S&P 500 lost 459.00 13.66 0.49%.respectively. 1,540.45 9.14 ! European markets European shares were sharply lower Monday morning, as investors reacted to weaker-than- expected economic data and the collapse of one of the world’s most well-known tour operators. BAJFINANCE 4,032.00 8.91 19,450.00 8.90 TOP LOSERS CLOSE CHANGE (%) 277.05 -8.08 765.00 -4.97 187.65 -4.36 TATAMOTOR 127.70 -4.17 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE CLOSE STRATEGY BUY ON DIPS 143.75 8.45 PIVOT POINTS R1 R2 11811 R3 12034 1650 7.22 11142 11365 11588 11705 730 7.30 S1-11482 S2-11365 R1-11705 R2-11811 1540.45 9.14 CLOSE -2.20 NTPC -3.17 -3.42 -4.97 NET INSTITUTION SELL (CR) FII 16996.5 8173.59 STRATEGY BUY ON DIPS NSE TOTALS DECLINE S PIVOT POINTS P 30305 SUPPORT S1 31019 R1 R2 R3 20019 32591 31448 29876 29162 RESISTANCE R1-29876 R2-29162 NIFTY BANK NIFTY Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! Cadila gets EIR for API manufacturing facility at Anklesh war (unit 1) from USFDA Shares of Cadila Healthcare are trading flat on the BSE. The company’s API located at Ankles war (Unit 1), Gujarat has received an Establishment Inspection Report (EIR). The USFDA had conducted an inspection at the facility from 22nd to 26th July 2019. The EIR report stated classification of the facility is no Action Indicated (NAI) â. Cadila Healthcare Ltd is Rs246.95 down by Rs0.3 or 0.12% from its previous closing of Rs247.25 on the BSE. Canara Bank to sell stake in Commonwealth Trust (India) Shares of Canara Bank are trading higher by over 2%. The bank informed the exchanges on Wednesday that the investment committee of the bank has initiate the process of stake sale in Commonwealth Trust (India) Ltd. The bank has invited an expression of interest (EOI) for the sale of 37,500 equity shares, representing 30% of the paid-up share capital held by Canara Bank in M/s Commonwealth Trust (India) Ltd. Canara Bank is currently trading at Rs207 up by Rs5.4 or 2.68% from its previous closing of Rs201.60 on the BSE. facility permitted to full in M/S currently trading at Yes Bank clarifies on report stating fund houses' refusal to the bank. Yes Bank clarified a story in Deccan Herald that quoted three different sources who have claimed that "the bank had approached many fund houses to raise at least $250mn (about Rs1, 775cr), which no one was willing to give them." The bank further notified exchanges regarding facts: The article has conveniently given a miss to the recent capital raising exercise carried out by YES Bank by way of Qualified Institutional Placement (QIP) route to the tune of $275mn (which is equivalent to Rs1, 930cr). ! Alembic Pharma announces completion of USFDA Inspection at Aleor Dermaceutical Shares of Alembic Pharma zoomed 6% in the afternoon session after the company said in the press note that Aleor Dermaceuticals, a 60:40 joint venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies, has completed USFDA inspection at its formulation manufacturing facility in Gujarat. Aleor Dermaceuticals Ltd. (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Kara khadi, Gujarat, India; with one observation Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : BERGEPAINT DATE : 24/09/2019 SEGMENT : CASH CHART TYPE : Candlestick : NSE : NSE EXCHANGE EXCHANGE TECHNICAL INDICATORS USED : VOLUME.MACD, RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY BERGEPAINT CASH ABOVE 436 TGT 448 SL 422 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Cash Intraday Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.